ARS Pharmaceuticals Inc.

NASDAQ: SPRY · Real-Time Price · USD
14.53
0.06 (0.41%)
At close: Aug 15, 2025, 3:59 PM
14.53
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT

ARS Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
89.15M 30K 1.32M 5.51M
Cost of Revenue
977K 73K 319K 213K
Gross Profit
88.17M 30K 997K 5.29M
Operating Income
-3.08M -67.52M -35.52M -19.45M
Interest Income
n/a n/a n/a 800K
Pretax Income
8.29M -54.37M -34.68M -20.24M
Net Income
8M -54.37M -34.68M -20.24M
Selling & General & Admin
71.67M 47.28M 18.14M 4.69M
Research & Development
19.58M 20.27M 18.38M 20.27M
Other Expenses
n/a n/a n/a -213K
Operating Expenses
91.25M 67.55M 36.51M 24.75M
Interest Expense
n/a n/a n/a 106K
Selling & Marketing Expenses
n/a n/a 200K n/a
Cost & Expenses
92.23M 67.55M 36.83M 24.96M
Income Tax Expense
288K n/a n/a n/a
Shares Outstanding (Basic)
96.94M 95.22M 39.96M 28.87M
Shares Outstanding (Diluted)
102.39M 95.22M 39.96M 28.87M
EPS (Basic)
0.08 -0.57 -0.87 -0.7
EPS (Diluted)
0.08 -0.57 -0.87 -0.7
EBITDA
-2.88M -67.45M -34.36M -19.24M
EBIT
-3.08M -67.52M -34.68M -19.45M
Depreciation & Amortization
208K 73K 319K 213K